Primary diffuse large B-cell lymphoma of bone displays preferential rearrangements of the c-MYC or BCL2 gene

被引:20
|
作者
Lima, Francisco Pignataro [1 ,2 ,4 ,5 ]
Bousquet, Marina [1 ,2 ]
Gomez-Brouchet, Anne [3 ]
de Paiva, Geisilene Russano [3 ]
Amstalden, Eliane Maria Ingrid [5 ]
Soares, Fernando Augusto [6 ]
Dastugue, Nicole [1 ,2 ]
Vassallo, Jose [5 ]
Brousset, Pierre [1 ,2 ]
机构
[1] Ctr Physiopathol Toulouse Purpan, INSERM, Toulouse, France
[2] Univ Toulouse 3, Dept Pathol, F-31062 Toulouse, France
[3] Hop Rangueil, Dept Pathol, Toulouse, France
[4] Purpan Hosp, Cytogenet Lab, Toulouse, France
[5] Univ Estadual Campinas, Fac Med Sci, Dept Pathol, Campinas, Brazil
[6] Hosp Canc, Dept Pathol, Sao Paulo, Brazil
关键词
BCL2; c-MYC; fluorescence in situ hybridization; FISH; bone; B-cell lymphoma;
D O I
10.1309/CMPGPYTMFRM6RVQR
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We selected a series of 63 primary diffuse large B-cell lymphomas (DLBCLs) of bone collected in tissue microarrays from centers in France and Brazil. These cases were classified according to the expression of antigens associated with germinal center (GC; n = 42) or non-GC (n = 21) stages of B-cell differentiation. By fluorescence in situ hybridization, we found a substantial number of cases with a rearrangement of BCL2 (9132) and c-MYC (n = 3), whereas the PAX5, BCL6, BCL1/cyclin D1, and ALK genes were in germline configuration. It is interesting that I case, with a GC phenotype, showed dual B CL2 and c-MYC rearrangement. The majority of the cases with rearrangements were of the GC phenotype. These results, associated with the lack of BCL6 rearrangement, suggest that bone DLBCL represents a specific group within extranodal B-cell lymphomas.
引用
收藏
页码:723 / 726
页数:4
相关论文
共 50 条
  • [21] Immunostains for C-MYC and BCL2 Protein Predict Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab
    Perry, A.
    Alvarado-Bernal, Y.
    Laurini, J.
    Smith, L.
    Fu, K.
    Aoun, P.
    Greiner, T.
    Chan, W.
    Bierman, P.
    Bociek, G.
    Armitage, J.
    Vose, J.
    Weisenburger, D.
    MODERN PATHOLOGY, 2012, 25 : 361A - 361A
  • [22] Immunostains for C-MYC and BCL2 Protein Predict Survival in Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab
    Perry, A.
    Alvarado-Bernal, Y.
    Laurini, J.
    Smith, L.
    Fu, K.
    Aoun, P.
    Greiner, T.
    Chan, W.
    Bierman, P.
    Bociek, G.
    Armitage, J.
    Vose, J.
    Weisenburger, D.
    LABORATORY INVESTIGATION, 2012, 92 : 361A - 361A
  • [23] Myc rearrangement and concurrent high protein expression of C-Myc/Bcl2 carry an adverse prognosis in diffuse large B-cell lymphoma
    Wang, Xingyu
    He, Juan
    He, Hong
    Shuai, Yuhan
    Wang, Lixin
    Li, Yuanxin
    Huang, Ying
    Yu, Kuai
    Zhao, Min
    Xie, Tao
    Li, Dan
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2023, 66
  • [24] C-MYC and bCL2 translocation frequency in diffuse large B cell lymphomas
    Akkaya, H.
    Akkaya, B.
    Salim, O.
    Ozcan, M.
    Yucel, O. K.
    Erdem, R.
    Iltar, U.
    Undar, L.
    VIRCHOWS ARCHIV, 2015, 467 : S195 - S195
  • [25] C-MYC AND BCL2 TRANSLOCATION FREQUENCY IN DIFFUSE LARGE B CELL LYMPHOMAS
    Akkaya, B.
    Salim, O.
    Akkaya, H.
    Ozcan, M.
    Yucel, O. K.
    Erdem, R.
    Iltar, U.
    Undar, L.
    HAEMATOLOGICA, 2015, 100 : 395 - 395
  • [26] Mediastinal B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements
    Ocal, Jon L.
    Feldman, Andrew L.
    Greipp, Patricia T.
    Rimsza, Lisa M.
    JOURNAL OF HEMATOPATHOLOGY, 2022, 15 (03) : 151 - 155
  • [27] Mediastinal B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements
    Jon L. Ocal
    Andrew L. Feldman
    Patricia T. Greipp
    Lisa M. Rimsza
    Journal of Hematopathology, 2022, 15 : 151 - 155
  • [28] Diffuse large B-cell lymphoma with concomitant c-MYC and BCL6 gene rearrangements with primary skin involvement: A case report and a review of literature
    Gabeeva, N. G.
    Koroleva, D. A.
    Belyaeva, A. V.
    Chernova, N. G.
    Kuzmina, L. A.
    Sudarikov, A. B.
    Obukhova, T. N.
    Kovrigina, A. M.
    Zvonkov, E. E.
    Savchenko, V. G.
    TERAPEVTICHESKII ARKHIV, 2017, 89 (07) : 85 - 92
  • [29] PATIENTS WITH PRIMARY CNS LYMPHOMA OR PRIMARY TESTICULAR DIFFUSE LARGE B-CELL LYMPHOMA HAVE AN INFERIOR PROGNOSIS WHEN CO-EXPRESSING C-MYC AND BCL2
    Troppan, K.
    Beham, C.
    Greinix, H.
    Deutsch, A.
    Neumeister, P.
    HAEMATOLOGICA, 2016, 101 : 400 - 401
  • [30] Clinical impact of BCL2, BCL6 and c-MYC rearrangements in diffuse large B cell lymphoma patients treated with R-CHOP
    Copie-Bergman, C.
    Baia, M.
    Molina, T. J.
    Mounier, N.
    Briere, J.
    Leroy, K.
    Tilly, H.
    Gisselbrecht, C.
    Haioun, C.
    Coiffier, B.
    Gaulard, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 106 - 106